Synopsys, Inc. $SNPS Stock Holdings Lowered by Ilmarinen Mutual Pension Insurance Co

Ilmarinen Mutual Pension Insurance Co lowered its position in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 20.6% in the 3rd quarter, Holdings Channel.com reports. The fund owned 18,511 shares of the semiconductor company’s stock after selling 4,809 shares during the quarter. Ilmarinen Mutual Pension Insurance Co’s holdings in Synopsys were worth $8,051,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in SNPS. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in shares of Synopsys in the 2nd quarter worth $747,400,000. Man Group plc purchased a new position in shares of Synopsys in the second quarter worth $55,900,000. Retail Employees Superannuation Pty Ltd as trustee for Retail Employees Superannuation Trust raised its stake in shares of Synopsys by 21.3% in the third quarter. Retail Employees Superannuation Pty Ltd as trustee for Retail Employees Superannuation Trust now owns 31,144 shares of the semiconductor company’s stock worth $13,546,000 after purchasing an additional 5,476 shares during the last quarter. Nykredit A S bought a new position in shares of Synopsys during the second quarter valued at $23,158,000. Finally, Bank of America Corp DE bought a new position in shares of Synopsys during the second quarter valued at $539,986,000. 85.47% of the stock is currently owned by hedge funds and other institutional investors.

Key Headlines Impacting Synopsys

Investors following SNPS have been watching these headlines:

  • Positive Sentiment: Synopsys-backed Ansys is supporting an integration between Instem’s toxicology tools and its simulation platform, extending the company’s reach into packaging safety and materials-risk workflows. This could broaden use of its simulation ecosystem, though the financial impact is not specified. Synopsys broadens platform reach
  • Neutral Sentiment: Synopsys is described as having stronger forward growth and a lower forward valuation multiple than Cadence, but Cadence is credited with a stronger balance sheet and returns on capital. Synopsys vs. Cadence
  • Negative Sentiment: A valuation analysis argues SNPS may be about 17% overvalued despite improving guidance and business performance, raising questions about whether future cash generation justifies the share price. Synopsys may be overvalued

Analyst Upgrades and Downgrades

SNPS has been the topic of several recent analyst reports. Deutsche Bank reaffirmed a “buy” rating and set a $640.00 price objective (up from $590.00) on shares of Synopsys in a research report on Thursday, October 1st. HSBC lowered Synopsys from a “buy” rating to a “reduce” rating in a research report on Friday, September 25th. Wells Fargo & Company upped their target price on shares of Synopsys from $475.00 to $540.00 and gave the company an “overweight” rating in a research note on Thursday, October 1st. Rothschild & Co Redburn dropped their price target on shares of Synopsys from $560.00 to $550.00 and set a “buy” rating on the stock in a report on Wednesday, September 23rd. Finally, KeyCorp lifted their price target on shares of Synopsys from $600.00 to $605.00 and gave the stock an “overweight” rating in a research note on Thursday, October 1st. One investment analyst has rated the stock with a Strong Buy rating, twenty-two have given a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $577.71.

View Our Latest Analysis on SNPS

Synopsys Trading Down 8.0%

Synopsys stock opened at $396.55 on Friday. Synopsys, Inc. has a 52-week low of $362.55 and a 52-week high of $539.48. The company has a market cap of $76.00 billion, a P/E ratio of 70.06, a P/E/G ratio of 1.40 and a beta of 1.18. The company has a quick ratio of 1.24, a current ratio of 1.34 and a debt-to-equity ratio of 0.29. The business has a 50-day simple moving average of $448.46 and a two-hundred day simple moving average of $440.14.

Synopsys (NASDAQ:SNPS – Get Free Report) last posted its quarterly earnings data on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.67 by $0.24. The company had revenue of $2.48 billion for the quarter, compared to the consensus estimate of $2.44 billion. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. The firm’s revenue was up 42.4% compared to the same quarter last year. During the same quarter last year, the firm posted $3.39 earnings per share. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. Analysts predict that Synopsys, Inc. will post 11.01 EPS for the current year.

Synopsys declared that its Board of Directors has initiated a share buyback plan on Monday, October 5th that authorizes the company to repurchase $1 billion in shares. This buyback authorization authorizes the semiconductor company to buy up to 1.1% of its stock through open market purchases. Stock buyback plans are often an indication that the company’s leadership believes its shares are undervalued.

Insider Buying and Selling at Synopsys

In other news, insider Janet Lee sold 1,144 shares of the business’s stock in a transaction on Tuesday, October 6th. The shares were sold at an average price of $502.52, for a total transaction of $574,882.88. Following the completion of the sale, the insider owned 16,534 shares of the company’s stock, valued at $8,308,665.68. The trade was a 6.47% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Sudhindra Kankanwadi sold 9,170 shares of the company’s stock in a transaction on Tuesday, October 6th. The stock was sold at an average price of $500.00, for a total value of $4,585,000.00. Following the completion of the sale, the chief financial officer owned 22,717 shares of the company’s stock, valued at $11,358,500. This trade represents a 28.76% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 117,163 shares of company stock worth $51,366,457. 0.56% of the stock is owned by insiders.

Synopsys Company Profile

(Free Report)

Synopsys, Inc. develops software, semiconductor intellectual property (IP) and services used to design and verify electronic systems. Its electronic design automation (EDA) tools help customers create, simulate, test and validate chips and other complex electronic products, while its IP portfolio provides reusable building blocks for semiconductor designs. The company also offers software security and quality tools that help developers identify vulnerabilities and assess applications throughout the software development process.

Read More

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.